Although breast tumors are usually classified as either hormone receptor (HR)-positive/HER2-negative, HER2-positive, or triple-negative based on expression of receptors at diagnosis, the emergence of clones with phenotypically distinct characteristics may occur. Here, ERBB2 is linked to breast neoplasm.